Mapping the immune cell landscape of severe atopic dermatitis by single‐cell RNA ‐seq
Allergy · 2024-06 · 79 (6) · 1584-1597
DOI: 10.1111/all.16121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergy, online erschienen am 31.05.2024. Verfasst von Seon-Pil Jin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Seoul National University Hospital, Seoul, Korea. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Single-Cell Analysis, Severity of Illness Index, RNA-Seq. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Research Foundation of Korea, Younsei University Research Fund.
Abstract (Originalsprache)
Background
Efforts to profile atopic dermatitis (AD) tissues have intensified, yet comprehensive analysis of systemic immune landscapes in severe AD remains crucial.
Methods
Employing single‐cell RNA sequencing, we analyzed over 300,000 peripheral blood mononuclear cells from 12 severe AD patients (Eczema area and severity index (EASI) > 21) and six healthy controls.
Results
Results revealed significant immune cell shifts in AD patients, including increased Th2 cell abundance, reduced NK cell clusters with compromised cytotoxicity, and correlated Type 2 innate lymphoid cell proportions with disease severity. Moreover, unique monocyte clusters reflecting activated innate immunity emerged in very severe AD (EASI > 30). While overall dendritic cells (DCs) counts decreased, a distinct Th2‐priming subset termed “Th2_DC” correlated strongly with disease severity, validated across skin tissue data, and flow cytometry with additional independent severe AD samples. Beyond the recognized role of Th2 adaptive immunity, our findings highlight significant innate immune cell alterations in severe AD, implicating their roles in disease pathogenesis and therapeutic potentials.
Conclusion
Apart from the widely recognized role of Th2 adaptive immunity in AD pathogenesis, alterations in innate immune cells and impaired cytotoxic cells have also been observed in severe AD. The impact of these alterations on disease pathogenesis and the effectiveness of potential therapeutic targets requires further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Seoul National University Hospital, Seoul, Korea.
- Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea.
- Institute of Human-Environmental Interface Biology, Medical Research Center, Seoul National University, Seoul, Korea.
- Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea.
- Brain Korea 21 (BK21) FOUR Program, Yonsei Education & Research Center for Biosystems, Yonsei University, Seoul, Korea.
- Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea.
ORCID-Profile: Seon-Pil Jin, Kyungchun Lee, Hyun Je Kim, Seunghee Hong, Dong Hun Lee
Förderung
- National Research Foundation of Korea
- Younsei University Research Fund
Zitieren
APA
Jin, S. P., Lee, K., Bang, Y. J., Jeon, Y. H., Jung, S., Choi, S. J., Lee, J. S., Kim, J., Guttman-Yassky, E., Park, C. G., Kim, H. J., Hong, S., & Lee, D. H. (2024). Mapping the immune cell landscape of severe atopic dermatitis by single‐cell RNA ‐seq. Allergy, 79(6), 1584-1597. https://doi.org/10.1111/all.16121
Vancouver
Jin SP, Lee K, Bang YJ, Jeon YH, Jung S, Choi SJ, et al. Mapping the immune cell landscape of severe atopic dermatitis by single‐cell RNA ‐seq. Allergy. 2024;79(6):1584-1597. doi:10.1111/all.16121
BibTeX
@article{Jin2024,
author = {Jin, Seon-Pil and Lee, Kyungchun and Bang, Yoon Ji and Jeon, Yun-Hui and Jung, Sunyoung and Choi, So-Jung and Lee, Ji Su and Kim, Junhan and Guttman-Yassky, Emma and Park, Chung-Gyu and Kim, Hyun Je and Hong, Seunghee and Lee, Dong Hun},
title = {Mapping the immune cell landscape of severe atopic dermatitis by single‐cell RNA ‐seq},
journal = {Allergy},
year = {2024},
volume = {79},
number = {6},
pages = {1584--1597},
doi = {10.1111/all.16121}
}
EUVIMED